tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMAB Stock Latest News

I-Mab’s Transformative Year: Financial and Strategic Highlights
Company AnnouncementsI-Mab’s Transformative Year: Financial and Strategic Highlights
3d ago
IMAB
I-Mab Positions for Growth with U.S. Focus and Innovative Cancer Treatments
PremiumCompany Announcements
I-Mab Positions for Growth with U.S. Focus and Innovative Cancer Treatments
3d ago
6K
IMAB
Promising Pipeline and Strong Financial Position Drive Buy Rating for I-Mab
PremiumRatings
Promising Pipeline and Strong Financial Position Drive Buy Rating for I-Mab
3d ago
IMAB
I-Mab price target lowered to $7 from $8 at H.C. Wainwright
PremiumThe Fly
I-Mab price target lowered to $7 from $8 at H.C. Wainwright
3d ago
IMAB
I-Mab Reports 2024 Financial Results and Strategic Progress
PremiumCompany Announcements
I-Mab Reports 2024 Financial Results and Strategic Progress
4d ago
6K
IMAB
IMAB Earnings this Week: How Will it Perform?
PremiumPre-EarningsIMAB Earnings this Week: How Will it Perform?
15d ago
IMAB
I-Mab Receives Nasdaq Deficiency Notice for Minimum Bid Price
Premium
Company Announcements
I-Mab Receives Nasdaq Deficiency Notice for Minimum Bid Price
17d ago
6K
IMAB
I-Mab receives Nasdaq deficiency notice
Premium
The Fly
I-Mab receives Nasdaq deficiency notice
17d ago
IMAB
I-Mab announces accelerated givastomig Phase 1b study progress
PremiumThe Fly
I-Mab announces accelerated givastomig Phase 1b study progress
1M ago
IMAB
I-Mab initiated with a Buy at Brookline
PremiumThe Fly
I-Mab initiated with a Buy at Brookline
1M ago
IMAB
I-Mab Advances Precision Immuno-Oncology Pipeline with Strategic Focus
PremiumCompany Announcements
I-Mab Advances Precision Immuno-Oncology Pipeline with Strategic Focus
1M ago
6K
IMAB
I-Mab management to meet virtually with BTIG
PremiumThe Fly
I-Mab management to meet virtually with BTIG
2M ago
IMAB
I-MAB Implements Workforce Reduction to Realign Operations
PremiumCompany AnnouncementsI-MAB Implements Workforce Reduction to Realign Operations
2M ago
6K
IMAB
I-Mab Biopharma Advances Precision Immuno-Oncology Programs Post-China Divestiture
Premium
Company Announcements
I-Mab Biopharma Advances Precision Immuno-Oncology Programs Post-China Divestiture
3M ago
6K
IMAB
I-Mab Board Chairman to Acquire $2 Million in ADSs
Premium
Company Announcements
I-Mab Board Chairman to Acquire $2 Million in ADSs
3M ago
6K
IMAB
I-Mab announces open market purchases of ADSs by board member
PremiumThe Fly
I-Mab announces open market purchases of ADSs by board member
3M ago
IMAB
I-Mab Prioritizes Givastomig as Lead Program in Strategic Shift
PremiumCompany Announcements
I-Mab Prioritizes Givastomig as Lead Program in Strategic Shift
3M ago
6K
IMAB
I-Mab announces givastomig as lead program
PremiumThe Fly
I-Mab announces givastomig as lead program
3M ago
IMAB
I-Mab Biopharma’s Strategic Shift to US-Based Biotech
PremiumCompany Announcements
I-Mab Biopharma’s Strategic Shift to US-Based Biotech
4M ago
6K
IMAB
I-Mab’s Third Quarter Results: Progress in Cancer Immunotherapies
PremiumCompany AnnouncementsI-Mab’s Third Quarter Results: Progress in Cancer Immunotherapies
5M ago
IMAB
I-Mab’s Promising Q3 Results and Strategic Moves
Premium
Company Announcements
I-Mab’s Promising Q3 Results and Strategic Moves
5M ago
6K
IMAB
I-Mab reports Q3 EPS (25c) vs. (39c) last year
Premium
The Fly
I-Mab reports Q3 EPS (25c) vs. (39c) last year
5M ago
IMAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >